Purchase Order 75N92023P00393
Award Date
9/20/23
Potential Completion Date
9/19/24
Potential Value
$1M
Federal Agency
National Heart Lung and Blood Institute
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price delivery order was awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $84,341 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, consumables, and related services to support genomic sequencing and analysis for research and diagnostic...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Human Genome Research Institute awarded Illumina, Inc., a for-profit manufacturer of genetic sequencing systems and analytics, a firm fixed-price purchase order contract worth $803,760.00 for a NovaSeq 6000 sequencing system. The contract was awarded on December 7, 2017 with a completion date of December 31, 2020. Illumina has previously provided a range of sequencing instruments, reagents, and...
This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $646,396.36 and no set-aside designation. Illumina, a manufacturer of sequencing and array-based genomic analysis solutions, will provide a range of sequencing systems, reagents, and services to support NHLBI's research and diagnostics needs. Illumina has a history of...
This is a firm fixed-price delivery order awarded by the National Heart, Lung, and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian federal agency. The $42,511.56 contract is for Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, to provide Illumina sequencing kits and reagents to support next-generation DNA sequencing activities at the NHLBI Sequencing Core Facility. The contract has a performance period ending on...
This is a federal contract award to Illumina, Inc., a manufacturer of genetic sequencing systems and related products, by the National Heart, Lung, and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH). The $94,636.62 firm fixed-price delivery order contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with associated reagents, consumables, and support services. The contract has no set-aside designation. Illumina...
This is a firm fixed-price delivery order awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical instruments. The contract, valued at $149,982.23, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance services,...
This $149,519.97 firm fixed price delivery order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Environmental Health Sciences to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The order is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, and bioinformatics support. The contract does...
This is a firm fixed price delivery order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The total ceiling value of the contract is $86,989.68. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, is providing a range of goods and services to support genomic sequencing and analysis for research and diagnostics purposes. This includes various NextSeq, NovaSeq, MiSeq, and...
This is a firm fixed-price delivery order contract awarded by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health, to Illumina, Inc., a manufacturer of sequencing and genomic analysis products. The contract, valued at $100,213.37, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance...
This is a firm fixed price delivery order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the provision of Illumina's sequencing kits and reagents to support the NHLBI Sequencing Core Facility's next-generation sequencing operations. The award has a ceiling value of $75,283.18 and an ultimate completion date of September 2, 2020. Illumina, a manufacturer of sequencing and genomic...